Farcomeni A - Search Results

1

Prognostic factors in patients receiving third line targeted therapy for metastatic renal cell carcinoma.

Iacovelli R, Farcomeni A, Sternberg CN, Cartenì G, Milella M, Santoni M, Cerbone L, Di Lorenzo G, Verzoni E, Ortega C, Sabbatini R, Ricotta R, Messina C, Lorusso V, Atzori F, De Vincenzo F, Sacco C, Boccardo F, Valduga F, Massari F, Baldazzi V, Cinieri S, Mosca A, Maria Ruggeri E, Berruti A, Procopio G. Iacovelli R, et al. Among authors: farcomeni a. J Urol. 2015 Jun;193(6):1905-10. doi: 10.1016/j.juro.2014.11.092. Epub 2014 Nov 26. J Urol. 2015. PMID: 25433306

2

Chemotherapy or targeted therapy as second-line treatment of advanced gastric cancer. A systematic review and meta-analysis of published studies.

Iacovelli R, Pietrantonio F, Farcomeni A, Maggi C, Palazzo A, Ricchini F, de Braud F, Di Bartolomeo M. Iacovelli R, et al. Among authors: farcomeni a. PLoS One. 2014 Sep 30;9(9):e108940. doi: 10.1371/journal.pone.0108940. eCollection 2014. PLoS One. 2014. PMID: 25268988 Free PMC article. Review.

3

Rationale and protocol of SOAP: a phase II study to evaluate the efficacy of sorafenib as second-line treatment after pazopanib in patients with advanced renal cell carcinoma.

Iacovelli R, Verzoni E, Grassi P, Farcomeni A, de Braud F, Procopio G. Iacovelli R, et al. Among authors: farcomeni a. Tumori. 2014 Nov-Dec;100(6):e282-5. doi: 10.1700/1778.19296. Tumori. 2014. PMID: 25688511 Clinical Trial.

4

Prevalence of malnutrition in patients at first medical oncology visit: the PreMiO study.

Muscaritoli M, Lucia S, Farcomeni A, Lorusso V, Saracino V, Barone C, Plastino F, Gori S, Magarotto R, Carteni G, Chiurazzi B, Pavese I, Marchetti L, Zagonel V, Bergo E, Tonini G, Imperatori M, Iacono C, Maiorana L, Pinto C, Rubino D, Cavanna L, Di Cicilia R, Gamucci T, Quadrini S, Palazzo S, Minardi S, Merlano M, Colucci G, Marchetti P; PreMiO Study Group. Muscaritoli M, et al. Among authors: farcomeni a. Oncotarget. 2017 Aug 10;8(45):79884-79896. doi: 10.18632/oncotarget.20168. eCollection 2017 Oct 3. Oncotarget. 2017. PMID: 29108370 Free PMC article.

5

An empirical broad spectrum antibiotic therapy in health-care-associated infections improves survival in patients with cirrhosis: A randomized trial.

Merli M, Lucidi C, Di Gregorio V, Lattanzi B, Giannelli V, Giusto M, Farcomeni A, Ceccarelli G, Falcone M, Riggio O, Venditti M. Merli M, et al. Among authors: farcomeni a. Hepatology. 2016 May;63(5):1632-9. doi: 10.1002/hep.28332. Epub 2016 Jan 5. Hepatology. 2016. PMID: 26529126 Clinical Trial.

6

Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae.

Falcone M, Russo A, Iacovelli A, Restuccia G, Ceccarelli G, Giordano A, Farcomeni A, Morelli A, Venditti M. Falcone M, et al. Among authors: farcomeni a. Clin Microbiol Infect. 2016 May;22(5):444-50. doi: 10.1016/j.cmi.2016.01.016. Epub 2016 Feb 3. Clin Microbiol Infect. 2016. PMID: 26850826 Free article.

7

A 3-variable prognostic score (3-PS) for overall survival prediction in metastatic castration-resistant prostate cancer treated with ²²³Radium-dichloride.

Frantellizzi V, Farcomeni A, Follacchio GA, Pacilio M, Pellegrini R, Pani R, De Vincentis G. Frantellizzi V, et al. Among authors: farcomeni a. Ann Nucl Med. 2018 Feb;32(2):142-148. doi: 10.1007/s12149-017-1228-6. Epub 2017 Dec 28. Ann Nucl Med. 2018. PMID: 29285670

8

Testicular histopathology, semen analysis and FSH, predictive value of sperm retrieval: supportive counseling in case of reoperation after testicular sperm extraction (TESE).

Gnessi L, Scarselli F, Minasi MG, Mariani S, Lubrano C, Basciani S, Greco PF, Watanabe M, Franco G, Farcomeni A, Greco E. Gnessi L, et al. Among authors: farcomeni a. BMC Urol. 2018 Jul 4;18(1):63. doi: 10.1186/s12894-018-0379-7. BMC Urol. 2018. PMID: 29973189 Free PMC article. Review.

9

Proton Pump Inhibitors Are Associated With Minimal and Overt Hepatic Encephalopathy and Increased Mortality in Patients With Cirrhosis.

Nardelli S, Gioia S, Ridola L, Farcomeni A, Merli M, Riggio O. Nardelli S, et al. Among authors: farcomeni a. Hepatology. 2019 Aug;70(2):640-649. doi: 10.1002/hep.30304. Epub 2019 Mar 4. Hepatology. 2019. PMID: 30289992

10

Primary Radical Prostatectomy or Ablative Radiotherapy as Protective Factors for Patients With mCRPC Treated With Radium-223 Dichloride: An Italian Multicenter Study.

Frantellizzi V, Costa R, Mascia M, Spanu A, Farcomeni A, Licari M, Cindolo L, Nuvoli S, Pontico M, De Vincentis G. Frantellizzi V, et al. Among authors: farcomeni a. Clin Genitourin Cancer. 2020 Jun;18(3):185-191. doi: 10.1016/j.clgc.2019.10.009. Epub 2019 Oct 16. Clin Genitourin Cancer. 2020. PMID: 32173355

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

230 results

Search Page